BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in BioCardia, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q3 2021
- Shares held
- 2.98M
- +111.3K (+3.9%) vs. Q3 2021
- Total value
- $5.78M
- −$3.23M (−35.9%) vs. Q3 2021
- New holders
- 4
- 6 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Roumell Asset Management, LLC | 938,380 | $1.82M | 2.43% | 00.0% | Unchanged |
| Captrust Financial Advisors | 660,637 | $1.28M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 411,969 | $799.0K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 329,000 | $638.0K | 0.48% | 00.0% | Unchanged |
| Family Management Corp | 142,186 | $276.0K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 76,825 | $149.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 65,791 | $128.0K | 0.00% | +21,994+50.2% | Added |
| Virtu Financial LLC | 56,419 | $109.0K | 0.01% | +56,419 | New |
| Citadel Advisors LLC | 51,976 | $101.0K | 0.00% | +32,692+169.5% | Added |
| Commonwealth Equity Services, LLC | 42,307 | $82.0K | 0.00% | +25,815+156.5% | Added |
| BlackRock Inc. | 36,114 | $70.0K | 0.00% | +935+2.7% | Added |
| Advisor Group Holdings, Inc. | 34,488 | $67.0K | 0.00% | −4,769−12.1% | Reduced |
| Brown Advisory Inc | 33,085 | $64.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 21,196 | $41.0K | 0.01% | +21,196 | New |
| Northern Trust Corp | 19,226 | $37.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,854 | $25.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 10,749 | $20.0K | 0.00% | +6,378+145.9% | Added |
| Bank of America Corp | 6,542 | $13.0K | 0.00% | +183+2.9% | Added |
| UBS Group AG | 5,813 | $11.0K | 0.00% | +5,813 | New |
| Tower Research Capital LLC (TRC) | 2,200 | $4.00K | 0.00% | +2,200 | New |
| Morgan Stanley | 983 | $2.00K | 0.00% | −400−28.9% | Reduced |
| Wells Fargo & Company | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −43,549−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,015−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −3,612−100.0% | Sold out |